LinkedIn Twitter Facebook

COUNTRY-SPECIFIC PHARMACOECONOMIC GUIDELINES
   Indicate one country
  Western EuropeNorthern EuropeSouthern EuropeEastern EuropeNorthern AmericaLatin AmericaAsiaOceaniaAfrica
PE GuidelinesBelgium
France
Germany
Switzerland
The Netherlands
Baltic (Latvia, Lithuania, Estonia)
Ireland
Norway
Sweden
Portugal
Slovak Republic
Canada
Brazil
Cuba
México
South Korea
Taiwan
New Zealand
Submission GuidelinesBritish Medical Journal
England & Wales
Finland
Scotland
Poland
United States of America
Israel
Thailand
Australia
Published PE RecommendationsAustria
Denmark
Italy
Spain
Hungary
Russian Federation
United States of America
China Mainland
South Africa

PE Guidelines Index Page

If you would like your country’s pharmacoeconomics guidelines at the ISPOR website or have comments concerning this section of the ISPOR website, email your request to mailto:PEguidelines@ispor.org

Contact ISPOR @ info@ispor.org  |  View Legal Disclaimer
©2012 International Society for Pharmacoeconomics and Outcomes Research. All rights reserved under International and Pan-American Copyright Conventions. 
Website design by Eagle Systems USA, Inc.